M&T Bank
PDLI

M&T Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

M&T Bank’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-53,161
Closed -$342K – 2207
2015
Q2 		$342K Sell
53,161
-41,895
-44% -$281K ﹤0.01% 1409
2015
Q1 		$669K Sell
95,056
-11,090
-10% -$80.3K ﹤0.01% 1047
2014
Q4 		$819K Buy
106,146
+32,214
+44% +$255K 0.01% 968
2014
Q3 		$552K Buy
73,932
+72,932
+7,293% +$677K ﹤0.01% 1194
2014
Q2 		$10K Buy
1,000
+500
+100% +$4.46K ﹤0.01% 942
2014
Q1 		$4K Hold
500
– – ﹤0.01% 1054
2013
Q4 		$4K Buy
+500
New +$4.21K ﹤0.01% 1009

Other funds holding PDLI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

M&T Bank's PDLI Position: Q3 2015 in Review

M&T Bank sold out of PDL BioPharma, Inc. (PDLI) in Q3 2015, closing a stake of 53,161 shares — an estimated $342K sold.

M&T Bank first reported a position in PDLI in Q4 2013 and held it in 7 quarters. The position peaked at $819K in Q4 2014. 213 funds tracked by Wall St. Rank hold PDLI as of Q3 2015.

  • M&T Bank reported no remaining PDL BioPharma, Inc. position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 53,161 PDL BioPharma, Inc. shares in Q3 2015, an estimated $342K.
  • M&T Bank first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 7 quarters.
  • M&T Bank's PDL BioPharma, Inc. position peaked at $819K in Q4 2014.
  • 213 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.